This website is intended for US healthcare professionals only.

  • Contact Us
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
  • Disease State Information & Resources
    • Hereditary Angioedema (HAE)
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
BioCryst logo
  • BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
    • Hereditary Angioedema (HAE)
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
  • Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study

    View Article

    biocryst

    January 27, 2025
    Hereditary Angioedema (HAE)
  • Hereditary angioedema: Epidemiology and burden of disease

    View Article

    biocryst

    January 27, 2025
    Hereditary Angioedema (HAE)
  • Severity of hereditary angioedema, prevalence, and diagnostic considerations

    View Article

    biocryst

    January 27, 2025
    Hereditary Angioedema (HAE)
  • Hereditary Angioedema

    View Article

    biocryst

    January 27, 2025
    Hereditary Angioedema (HAE)
  • Consequences of Insurance Coverage Delays and Denials for Patients With Hereditary Angioedema

    View Article

    biocryst

    January 27, 2025
    Hereditary Angioedema (HAE)
  • Prevalence of and risk factors for nutritional deficiency and food allergy in a cohort of 21 patients with Netherton syndrome

    View Article

    biocryst

    January 27, 2025
    Netherton Syndrome (NS)
  • Human papillomavirus infection in Netherton’s syndrome 

    View Article

    biocryst

    January 27, 2025
    Netherton Syndrome (NS)
  • The Spectrum of Pathogenic Mutations in SPINK5 in 19 Families with Netherton Syndrome: Implications for Mutation Detection and First Case of Prenatal Diagnosis

    View Article

    biocryst

    January 27, 2025
    Netherton Syndrome (NS)
  • Kallikreins: Essential epidermal messengers for regulation of the skin microenvironment during homeostasis, repair and disease

    View Article

    biocryst

    January 27, 2025
    Netherton Syndrome (NS)
  • Netherton Syndrome in Children: Management and Future Perspectives

    View Article

    biocryst

    January 27, 2025
    Netherton Syndrome (NS)
Previous Page
1 … 4 5 6 7 8 9
Next Page
BioCryst logo

2025 BioCryst Pharmaceuticals, Inc.
All Rights Reserved

  • Contact Us
  • Terms of Use
  • Privacy Notice
  • Site Map
Close

You are now leaving biocrystmedical.com.

BioCryst is not responsible for and has no control over the content of linked sites.

Stay on Site Continue

This website is intended for healthcare professionals practicing in the US.

Are you a US healthcare professional? If not, you will be redirected to biocryst.com.

No, I am not a US healthcare professional Yes, I am a US healthcare professional